Skip to main content
. 2013 Nov;34(11):2157–2162. doi: 10.3174/ajnr.A3574

Table 3:

Medication and stents

Antiplatelet regimen
    Clopidogrel 406 (86.7%)
    Ticlopidine 62 (13.3%)
Stents used for treatmenta,b
    Enterprise 340 (68%)
    Solitaire (Solo) 98 (19.6%)
    Wingspan 41 (8.2%)
    LEO 16 (3.2%)
    Neuroform 5 (1%)
a

Percentages are obtained over the total number of aneurysms treated (n = 500), whereas others are over the number of patients (n = 468).

b

Stents with technical failure are not included in this table.